RegMed XB 1st Annual Conference

Are you ready to join Quality Assistance at 
RegMed XB 1st Annual Conference?

 Axelle Vanderbeque, Senior Key Account Manager, and Pedro Alves, Scientific Manager Cells and ATMPs, will attend the Conference. Make sure to exchange with them about your analytical needs and challenges.

Quality Assistance is a partner of RegMed XB Consortium

RegMed XB stands for Regenerative Medicine Crossing Borders. It is a virtual institute of Dutch and Belgian public (universities and governments) and private (health foundations and companies) partners that will work together to develop regenerative medicine solutions to health challenges.

In this collaboration, Quality Assistance may contribute in various ways:

• Method development to assess quality, safety and efficacy of products
  • Wide range of analytical techniques available
  • Use of statistical tools during development steps (Analytical Quality by Design principles)
  • Robustness studies
• Expertise in the development of potency assays
• Method validation according to regulatory guidelines (ICH Q2, USP <1033>)
• Support on translation of “R&D grade” to “GxP-compliant” methods

In this collaboration, Quality Assistance is looking for:

• Access to “real” samples to assess the relevance and applicability of the methods we have developed in-house on model compounds
• Input on the analytical challenges faced during the pharmaceutical development
• Input on regulatory requirements regarding analytical packages

WHY PARTNER WITH QUALITY ASSISTANCE?

Quality Assistance is a leading European Contract Research Organisation providing the pharmaceutical industry with all the analytical services required by EMA and FDA regulations for the development and marketing of innovative human medicinal products.

The company holds a unique place on the market with all of its laboratories on one site, 250 highly-qualified professionals and more than 40 years’ expertise at the forefront of analytical sciences.

They assist their clients from candidate selection, through non-clinical and clinical studies, to marketing authorisation, using their state-of-the-art, product-dedicated expertise in analytical sciences. For each customer and each project, they design customised solutions, define analytical protocols, develop and validate specific new analytical methods and perform characterisation, stability, pharmacokinetic, biomarker and immunogenicity studies as well as batch release testing, in order to evaluate the Quality, Safety and Efficacy of the given drugs.

Visit https://regmedxb.com/annual-conference-2023 for more information about the conference

SCHEDULE A MEETING WITH OUR TEAM